These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 9623096)

  • 1. [Immunology in medical practice. XIV. Central nervous system complications in systemic autoimmune diseases].
    Markusse HM; van den Bent MJ; Vecht CJ
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):508-12. PubMed ID: 9623096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognitive and psychotic effects after cessation of chronic cannabis use].
    van Amsterdam JG; van der Laan JW; Slangen JL
    Ned Tijdschr Geneeskd; 1998 Mar; 142(10):504-8. PubMed ID: 9623095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of Sjögren's syndrome to other connective tissue and autoimmune disorders.
    Theander E; Jacobsson LT
    Rheum Dis Clin North Am; 2008 Nov; 34(4):935-47, viii-ix. PubMed ID: 18984413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Difficulties in differential diagnosis of Sjögren's syndrome and systemic lupus erythematosus].
    Krawiec P; Batko B; Skura A; Adamek-Guzik T; Cześnikiewicz-Guzik M; Krzanowski M; Rydz-Stryszowska I; Ryszawa N; Guzik TJ
    Przegl Lek; 2006; 63(5):278-83. PubMed ID: 17036505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic dysfunction in autoimmune diseases: consequence or cause?
    Mravec B
    Lupus; 2007; 16(9):767-8. PubMed ID: 17728374
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurolupus.
    Joseph FG; Scolding NJ
    Pract Neurol; 2010 Feb; 10(1):4-15. PubMed ID: 20130291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): patterns of clinical and immunological expression in 180 cases.
    Ramos-Casals M; Jara LJ; Medina F; Rosas J; Calvo-Alen J; Mañá J; Anaya JM; Font J;
    J Intern Med; 2005 Jun; 257(6):549-57. PubMed ID: 15910559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dual association between lymphoma and autoimmunity.
    Ehrenfeld M; Abu-Shakra M; Buskila D; Shoenfeld Y
    Blood Cells Mol Dis; 2001; 27(4):750-6. PubMed ID: 11778659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Systemic lupus erythematosus and the central nervous system].
    Rojas E; Orrea Solano M
    Rev Alerg; 1993; 40(2):46-9. PubMed ID: 9312334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune and iatrogenic causes of lymphadenopathy.
    Segal GH; Clough JD; Tubbs RR
    Semin Oncol; 1993 Dec; 20(6):611-26. PubMed ID: 8296198
    [No Abstract]   [Full Text] [Related]  

  • 14. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune disorders associated with acquired autoimmune myasthenia gravis].
    Nakao N; Sahashi K
    Ryoikibetsu Shokogun Shirizu; 2001; (36):347-50. PubMed ID: 11596406
    [No Abstract]   [Full Text] [Related]  

  • 16. The impact of autoimmune disorders and adverse pregnancy outcome.
    Mecacci F; Pieralli A; Bianchi B; Paidas MJ
    Semin Perinatol; 2007 Aug; 31(4):223-6. PubMed ID: 17825677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurologic manifestations of primary Gougerot-Sjögren syndrome].
    Lafitte C
    Rev Neurol (Paris); 1998 Oct; 154(10):658-73. PubMed ID: 9846336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic complications of systemic lupus erythematosus.
    Delaney P
    Am Fam Physician; 1983 Jul; 28(1):191-3. PubMed ID: 6869169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic autoimmune diseases in patients with hepatitis C virus infection: characterization of 1020 cases (The HISPAMEC Registry).
    Ramos-Casals M; Muñoz S; Medina F; Jara LJ; Rosas J; Calvo-Alen J; Brito-Zerón P; Forns X; Sánchez-Tapias JM;
    J Rheumatol; 2009 Jul; 36(7):1442-8. PubMed ID: 19369460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of neurological disorders in systemic vasculitis.
    Gold R; Fontana A; Zierz S
    Semin Neurol; 2003 Jun; 23(2):207-14. PubMed ID: 12894386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.